Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pallavi Mandal

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|January 14, 2014
Bronchiectasis: an update on current pharmacotherapy and future perspectivesManjit K Sidhu, Pallavi Mandal, Adam T Hill
Expert Opinion on Investigational Drugs|October 14, 2014
Developing drug therapies in bronchiectasisManjit K Sidhu, Pallavi Mandal, Adam T Hill
Journal of Fluorescence|August 16, 2025
Eco-friendly Nano-scale Bio-analytical Insights for Spectrofluorimetric Estimation of Fimasartan Using Integrated Approach of Enhanced Microwave-assisted Hantzsch Reaction and Multicolored Analytical ChemistryPintu Prajapati, Pallavi Mandal, Hiral Solanki, et al.
Respiratory Medicine|May 8, 2010
Statins in community acquired pneumonia: Evidence from experimental and clinical studiesJames D Chalmers, Philip M Short, Pallavi Mandal, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2010
Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumoniaJames D Chalmers, Aran Singanayagam, Ahsan R Akram, et al.
Chest|May 4, 2010
Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumoniaAhsan R Akram, Aran Singanayagam, Gourab Choudhury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2011
Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit careJames D Chalmers, Joanne K Taylor, Pallavi Mandal, et al.
Intensive Care Medicine|June 11, 2011
Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysisJames D Chalmers, Pallavi Mandal, Aran Singanayagam, et al.
Thorax|August 24, 2010
Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysisJames D Chalmers, Aran Singanayagam, Ahsan R Akram, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort studyJames D Chalmers, Joanne K Taylor, Aran Singanayagam, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|January 14, 2014
Bronchiectasis: an update on current pharmacotherapy and future perspectivesManjit K Sidhu, Pallavi Mandal, Adam T Hill
Expert Opinion on Investigational Drugs|October 14, 2014
Developing drug therapies in bronchiectasisManjit K Sidhu, Pallavi Mandal, Adam T Hill
Journal of Fluorescence|August 16, 2025
Eco-friendly Nano-scale Bio-analytical Insights for Spectrofluorimetric Estimation of Fimasartan Using Integrated Approach of Enhanced Microwave-assisted Hantzsch Reaction and Multicolored Analytical ChemistryPintu Prajapati, Pallavi Mandal, Hiral Solanki, et al.
Respiratory Medicine|May 8, 2010
Statins in community acquired pneumonia: Evidence from experimental and clinical studiesJames D Chalmers, Philip M Short, Pallavi Mandal, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2010
Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumoniaJames D Chalmers, Aran Singanayagam, Ahsan R Akram, et al.
Chest|May 4, 2010
Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumoniaAhsan R Akram, Aran Singanayagam, Gourab Choudhury, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2011
Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit careJames D Chalmers, Joanne K Taylor, Pallavi Mandal, et al.
Intensive Care Medicine|June 11, 2011
Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysisJames D Chalmers, Pallavi Mandal, Aran Singanayagam, et al.
Thorax|August 24, 2010
Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysisJames D Chalmers, Aran Singanayagam, Ahsan R Akram, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2011
Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort studyJames D Chalmers, Joanne K Taylor, Aran Singanayagam, et al.
Pageof 2